Dr David Brookes

Non-Executive Director

Dr David Brookes has extensive experience in the health and biotechnology industries, including Board positions in numerous ASX listed biotechnology companies, Chairman of genomics solutions company, RHS Ltd, which was acquired by PerkinElmer Inc. Recently successfully exited Better Medical group, of which he was previously Non-Executive Chairman.

He is currently a Non-Executive Director of Factor Therapeutics (ASX: FTT) and of Anatara Lifesciences Ltd (ASX:ANR).

Dr Brookes has an MBBS (Adelaide), is a Fellow of the Australian College of Rural and Remote Medicine and a Fellow of the Australian Institute of Company Directors.